Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06433674
Other study ID # 23-09580-FB
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date June 1, 2024
Est. completion date July 1, 2025

Study information

Verified date June 2024
Source University of Tennessee
Contact Andrew C Mire, M.D.
Phone 2255884831
Email amire@uthsc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to observe for changes in rate of weight gain in the very low birth weight (VLBW) infants by adding an enteral Zinc supplement of 1 mg/kg/day of elemental zinc. The main question it aims to answer: • Does an enteral Zinc supplement of 1 mg/kg/day increase rate of weight gain in VLBW infants Researches will compare the experimental group to a placebo group to see if there is a statistical difference in rate of weight gain between the two groups - Once the participants have reached 100 ml/kg/day of enteral feeds. The participants will be randomized to one of two groups. The treatment group will receive ~1 mg/kg/day of elemental enteral Zinc, and the control group to receive similar amount of enteral sterile water put in a colored syringe. The Zinc Supplement would be Zinc Sulfate. The primary team would otherwise be managing the patient's feeding using our hospital's feeding protocol. As long as the patient is tolerating 100 ml/kg/day of enteral feeds, the Zinc Supplement will continue until 36 weeks postmenstrual age (PMA) or hospital discharge, whichever comes first. - The participants will have three Zinc levels measured: once prior to Zinc Supplementation, once at around the four week mark, and once at the completion of therapy.


Description:

This is a prospective, single center, randomized, double blinded, placebo controlled clinical trial. The goal of this clinical trial is to observe for changes in rate of weight gain in the VLBW infants by adding an enteral Zinc supplement of 1 mg/kg/day of elemental zinc. The main question it aims to answer: • Does an enteral Zinc supplement of 1 mg/kg/day increase rate of weight gain in VLBW infants Researches will compare the experimental group to a placebo group to see if there is a statistical difference in rate of weight gain between the two groups - Once the participants have reached 100 ml/kg/day of enteral feeds. The participants will be randomized using sealed envelopes. The subjects will be randomly selected to one of two groups. The treatment group will receive ~1 mg/kg/day of elemental enteral Zinc, and the control group to receive similar amount of enteral sterile water put in a colored syringe. The Zinc Supplement would be Zinc Sulfate. Only the pharmacy will know which patient is receiving the Zinc Sulfate and which patient is receiving the placebo. The primary team would otherwise be managing the patient's feeding using our hospital's feeding protocol. As long as the patient is tolerating 100 ml/kg/day of enteral feeds, the Zinc Supplement will continue until 36 weeks PMA or hospital discharge, whichever comes first. - The participants will have three Zinc levels measured: once prior to Zinc Supplementation, once at around the four week mark, and once at the completion of therapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date July 1, 2025
Est. primary completion date July 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Weeks to 36 Weeks
Eligibility Inclusion Criteria: 1. Birth weight < 1500 grams 2. Infant is tolerating at least 100 ml/kg/day of enteral feeds 3. At least 25wks PMA. Exclusion Criteria: - Major congenital malformations especially anomaly of the GI tract - Major congenital heart disease (i.e.: ductal dependent lesion) - Previously diagnosed necrotizing enterocolitis (stage 2 or 3), bowel perforation, or bowel resection - Infant who has tolerated =100 ml/kg/day prior to admission.

Study Design


Intervention

Drug:
Zinc Sulfate
The pharmacy will be the one preparing the Zinc sulfate. The zinc sulfate comes in 220 mg tablets which are then mixed with 1 ml of Oral plus (a common suspending agent) as well as 9 ml of Sterile water. This then makes a Zinc Sulfate 22 mg/ml oral suspension which will be dispensed in an amber syringe.
Other:
Sterile Water
The placebo group with will receive a similar amount of sterile water in a colored syringe

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Tennessee

References & Publications (5)

Brion LP, Heyne R, Lair CS. Role of zinc in neonatal growth and brain growth: review and scoping review. Pediatr Res. 2021 May;89(7):1627-1640. doi: 10.1038/s41390-020-01181-z. Epub 2020 Oct 3. Erratum In: Pediatr Res. 2021 Mar 2;: — View Citation

Shaikhkhalil AK, Curtiss J, Puthoff TD, Valentine CJ. Enteral zinc supplementation and growth in extremely-low-birth-weight infants with chronic lung disease. J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):183-7. doi: 10.1097/MPG.0000000000000145. — View Citation

Sinha B, Dudeja N, Chowdhury R, Choudhary TS, Upadhyay RP, Rongsen-Chandola T, Mazumder S, Taneja S, Bhandari N. Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis. Pediatrics. 2022 Aug 1;150(Suppl 1):e2022057092J. doi: 10.1542/peds.2022-057092J. — View Citation

Terrin G, Berni Canani R, Di Chiara M, Pietravalle A, Aleandri V, Conte F, De Curtis M. Zinc in Early Life: A Key Element in the Fetus and Preterm Neonate. Nutrients. 2015 Dec 11;7(12):10427-46. doi: 10.3390/nu7125542. — View Citation

Terrin G, Berni Canani R, Passariello A, Messina F, Conti MG, Caoci S, Smaldore A, Bertino E, De Curtis M. Zinc supplementation reduces morbidity and mortality in very-low-birth-weight preterm neonates: a hospital-based randomized, placebo-controlled trial in an industrialized country. Am J Clin Nutr. 2013 Dec;98(6):1468-74. doi: 10.3945/ajcn.112.054478. Epub 2013 Sep 11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of weight gain The primary outcome would be the rate of weight gain in grams/kg/day at hospital discharge or 36 weeks PMA whichever comes first.
Secondary Length This secondary outcome would be the rate of length gain in cm/day at hospital discharge of 36 weeks PMA whichever comes first
Secondary Head Circumference This secondary outcome would be the rate of head circumference gain in cm/day at hospital discharge of 36 weeks PMA whichever comes first
Secondary Zinc level This secondary outcome would be looking for a statically significant difference in zinc level Comparing the initial zinc level to the four week zinc level as well as the zinc level at 36 weeks or discharge whichever comes first
See also
  Status Clinical Trial Phase
Recruiting NCT05603585 - Optimal Protein Supplementation and Early Exercise In Mechanically Ventilated Patients N/A
Recruiting NCT05417672 - Assessment of Relationship Between Preoperative Nutritional Status and Perioperative/Postoperative Conditions in Patients With Lung Cancer Scheduled for Lobectomy
Completed NCT04091165 - Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
Recruiting NCT05655910 - Enhanced Nutritional Optimization in LVAD Trial N/A
Completed NCT04117581 - A Study to Investigate the Effect of Vitamin D3 Supplementation on Asthma Symptoms in Adults With Asthma (VITDAS) N/A
Recruiting NCT06078488 - Individualized Nutritional Care Bundle for Home Nursing Patients With Pressure Injuries. N/A
Withdrawn NCT05073562 - Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia N/A
Completed NCT02208635 - Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months N/A
Recruiting NCT01342861 - INAPEN Protocol for Impact of Breakfast Improvement N/A
Completed NCT05244785 - Health and Nutrition Survey on Shenzhen Children
Recruiting NCT06103526 - Immunonutrition in ERAS Protocols in Gynecologic Oncology N/A
Completed NCT05473546 - Diarrhea and Stipsis in Critically Ill Patients (NUTRITI)
Completed NCT04829851 - The PROTEIN Project
Completed NCT03202576 - Nasogastric Tube Securement Comparison Study N/A
Completed NCT04351828 - Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
Completed NCT04866927 - Bioavailability of Proteins From Plant Based Diets
Completed NCT04771377 - Effect of Protein Supplementation and a Structured Exercise Program on Muscle in Women After Bariatric Surgery. N/A
Completed NCT04401930 - Eating Habits and Lifestyle Profile of an Italian Aging Cohort
Terminated NCT04629534 - Mothers' Own Milk Optimization for Preterm Infants Project (MoMO PIP) Pilot Study Phase 4
Completed NCT03133364 - Developing and Testing Delicious and Nutritious for the Old People N/A